Morgan Stanley Vs. JPMorgan: Which Big Bank Is the Better Buy This Year

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Morgan Stanley's $8.52B in sticky wealth fees and 27.1% ROTCE make MS a more defensive income bet than JPM's cyclical credit exposure.

  • JPMorgan's card charge-off rate hit 3.46% and nonperforming exposure rose 11% to $11 billion, testing whether Dimon's resilient consumer narrative survives year-end.

  • Morgan Stanley targets $10 trillion in client assets, and shares already up 52% over the past year reflect how durably its wealth fee flywheel compounds.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and JPMorgan Chase didn't make the cut. Grab the names FREE today.

Morgan Stanley Vs. JPMorgan: Which Big Bank Is the Better Buy This Year

© serts / E+ via Getty Images

Morgan Stanley (NYSE:MS | MS Price Prediction) and JPMorgan Chase (NYSE:JPM) both posted Q1 2026 results that showcased strength, yet the businesses behind those numbers look nothing alike. Morgan Stanley leaned on advisory fees and wealth flows. JPMorgan flexed a universal-bank engine touching cards, payments, and trading. Each firm’s core revenue engine now sits in a distinctly different part of finance.

Fee Flywheel at Morgan Stanley, Everything Machine at JPMorgan

Ted Pick called it “a record quarter”, and the composition matters. Wealth Management pulled in $8.52 billion with $118.4 billion in net new assets and $54 billion of fee-based flows. That is recurring, sticky revenue. Institutional Securities added $10.72 billion, with Advisory alone up 74%. Investment Management slipped 4% on $11.6 billion of equity outflows, a reminder the fee model still has soft spots.

JPMorgan showed scale that Morgan Stanley cannot match. The Commercial & Investment Bank generated $23.38 billion, Markets hit a record $11.6 billion, and Card Services & Auto climbed 13% to $7.76 billion. Consumer credit is a real engine here, and it cuts both ways. The Card net charge-off rate ran at 3.46%, and nonperforming exposure rose 11% to $11.0 billion.

Capital-Light Advisor vs. Cyclical Credit Colossus

Lens Morgan Stanley JPMorgan
Core Bet Wealth & advisory fees Universal bank scale
Q1 Revenue $20.58B $49.84B
EPS $3.43 $5.94
Client Assets $7.34T $7.1T
Trailing P/E 19 16

Morgan Stanley converts trillions in assets under management directly into predictable, high-margin advisory fee revenue. That shows up as a 27.1% ROTCE and an efficiency ratio compressed to 65%. JPMorgan holds #1 Global IB fees at 9.8% wallet share, but noninterest expense grew 14%, outpacing revenue.

The Next Test Is Credit Normalization and Wealth Flows

I will be watching whether Morgan Stanley can push toward its $10 trillion client-asset target while fixing the Investment Management outflows. Polymarket traders currently price a 51% chance MS Q2 IB revenue clears $2.125 billion, which is a real test of momentum. For JPMorgan, credit is the story. Card charge-offs and that rising nonperforming exposure will tell us whether Dimon’s “resilient” consumer holds through year-end.

The Case for Morgan Stanley’s Fee Durability

If I want cash-flow durability through a messy macro, I lean toward Morgan Stanley. The wealth engine keeps compounding whether markets chop or trend, and shares are already up 51.97% over the past year for a reason. JPMorgan fits a different investor, one who wants scale, a $1.50 quarterly dividend, and comfort owning the credit cycle. At 16 times earnings, it is cheaper than Morgan Stanley at 19, and that discount exists precisely because the cyclical exposure is real. The setup that would narrow the gap is credit metrics stabilizing at JPMorgan and its expense growth cooling. Until then, Morgan Stanley’s fee flywheel is the more defensive profile of the two.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

UHS Vol: 582,388
MRNA Vol: 8,809,465
HCA Vol: 851,961
BSX Vol: 13,678,153
TYL Vol: 206,467

Top Losing Stocks

TER Vol: 2,378,707
KLA
KLAC Vol: 10,357,777
GLW Vol: 13,480,329
STX Vol: 3,040,327
LRCX Vol: 7,801,735